NDC 50458-141 – Invokana
Canagliflozin 300 mg/1 · Tablet, Film Coated · Oral
Product NDC50458-141
Product details
- Brand name
- Invokana
- Generic name
- Canagliflozin
- Labeler
- Janssen Pharmaceuticals, Inc.
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- NDA · NDA204042
- Marketed since
- March 29, 2013
- Listing expires
- December 31, 2027
- Pharmacologic class
- Sodium-Glucose Cotransporter 2 Inhibitor
Active ingredients
- Canagliflozin 300 mg/1
Package NDC codes (5)
| Package NDC | Description | Since |
|---|---|---|
| 50458-141-01 sample | 5 TABLET, FILM COATED in 1 BOTTLE (50458-141-01) | Mar 29, 2013 |
| 50458-141-10 | 10 BLISTER PACK in 1 CARTON (50458-141-10) / 10 TABLET, FILM COATED in 1 BLISTER PACK | Mar 29, 2013 |
| 50458-141-30 | 30 TABLET, FILM COATED in 1 BOTTLE (50458-141-30) | Mar 29, 2013 |
| 50458-141-50 | 500 TABLET, FILM COATED in 1 BOTTLE (50458-141-50) | Mar 29, 2013 |
| 50458-141-90 | 90 TABLET, FILM COATED in 1 BOTTLE (50458-141-90) | Mar 29, 2013 |
Other Invokana products
- 50090-4364 Canagliflozin 300 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-5029 Canagliflozin 300 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 50090-5034 Canagliflozin 100 mg/1 · Tablet, Film Coated · A-S Medication Solutions
- 55154-1425 Canagliflozin 100 mg/1 · Tablet, Film Coated · Cardinal Health 107, LLC
- 55154-1426 Canagliflozin 300 mg/1 · Tablet, Film Coated · Cardinal Health 107, LLC
- 50458-140 Canagliflozin 100 mg/1 · Tablet, Film Coated · Janssen Pharmaceuticals, Inc.